Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: Morphologic correlation

Bone Marrow Transplantation

Volumn 22, Issue 11, 1998, Pages 1071-1076

  Bielski, M ^a,b   Yomtovian, R ^a   Lazarus, H M ^a   Rosenthal, N ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Hematopoietic stem cell transplantation; Isolated; Megakaryocyte; Thrombocytopenia

Indexed keywords

HLA ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; CELL DIFFERENTIATION; CELL NUCLEUS; CELL SIZE; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0031729830     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701499     Document Type: Article

References (33)

1. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
2. Bentley SA, Brecher ME, Powell E et al. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients. Bone Marrow Transplant 1997; 19: 557-563.
3. Cassileth PA, Andersen J, Lazarus HM et al. Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314-319.
4. Mick R, Williams SF, Bitran JD. Patients at increased risk for late engraftment after transplantation: a novel method for their identification. Bone Marrow Transplant 1990; 6: 185-191.
5. Sivakumaran M, Hutchinson RM, Pringle H et al. Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. Bone Marrow Transplant 1995; 15: 531-536.
6. Anasetti C, Rybka W, Sullivan KM et al. Graft-vs-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989; 73: 1054-1058.
7. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992; 339: 640-644.
8. Kickler TS, Anderson KC, Ness PM (eds). Scientific Basis of Transfusion Medicine: Implications for Clinical Practice. WB Saunders Co: Philadelphia, 1994, pp 308-314.
9. Hassan HT, Zander AR. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it, J Hematother 1996; 5: 407-414.
10. Pendry K, Alcorn MJ, Burnett AK. Factors influencing haematological recovery in 53 patients with acute myeloid leukemia in first remission after autologous bone marrow transplantation. Br J Haematol 1993: 83: 45-52.
11. Foucar K. Bone Marrow Pathology, ASCP Press; Chicago, 1995, pp 28-30.
12. Hollander M, Wolfe DA. Non-parametric Statistical Methods. John Wiley & Sons: New York, 1973. pp 71-79.
13. Lazarus HM, Andersen J, Chen MG et al. Recombinant GM-CSF after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A Phase II Eastern Cooperative Oncology Group Trial. Blood 1991; 78: 830-837.
14. Klumpp TR, Block CC, Caliguiri MA et al. Immune-mediated cytopenia following bone marrow transplantation: case reports and review of the literature. Medicine 1992; 71: 73-83.
15. Bradford G, Williams N, Barber L, Bertoncello I. Temporal thrombocytopenia after engraftment with defined stem cells with long-term marrow reconstituting activity. Exp Hematol 1993; 21: 1615-1620.
16. Cullen WC, McDonald TP. Comparison of stereologic techniques for the quantification of megakaryocyte size and number. Exp Hematol 1986; 14: 782-788.
17. Harker LA. Megakaryocyte quantification, J Clin Invest 1968; 47: 452-457.
18. Thiele J, Titius BR, Kvasnicka HM et al. Proliferating cell nuclear antigen (PCNA) expression of megakaryopoiesis in normal human bone marrow and reactive lesions with special emphasis on HIV-myelopathy. Pathol Res Practice 1994; 190: 42-50.
19. Spitzer G, Adkins DR. Persistent problems of neutropenia and thrombocytopenia with peripheral blood stem cell transplantation. J Hematother 1994; 3: 193-198.
20. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
21. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colonystimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031-2035.
22. Domenech J, Linassier C, Gihana E et al. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation. Blood 1995; 85: 3320-3327.
23. Quinones RR. Hematopoietic engraftment and graft failure after bone marrow transplantation. Am J Pediatr Hematol Oncol 1993; 15: 3-17.
24. Canals C, Marti JM, Martinez E et al. Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors. J Hematother 1993; 3: 75-85.
25. Bernstein SH, Nademanee AP, Vose JM et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood 1998; 91: 3509-3517.
26. Emmons RVB, Reid DM, Cohen RL et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87: 4068-4071.
27. Kaushansky K. Drug therapy: thrombopoietin. New Engl J Med 1998; 339: 746-754.
28. Cuthbert RJ, Shepherd JD, Nantel SH et al. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience. Clin Invest Med 1995; 18: 122-130.
29. Lazarus HM, Crilley P, Ciobanu N et al. High-dose carmustine, etoposide, cisplatin (BEP) and autologous bone marrow transplantation for relapsed and refractory lymphoma. J Clin Oncol 1992; 10: 1682-1689.
30. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
31. Antman K, Ayash L, Elias A et al. A phase II study of highdose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measureable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 1992; 10: 102-110.
32. Brown RA, Wolff SN, Fay JW et al. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Bone Marrow Transplant Group. Leuk Lymphoma 1996; 22: 271-277.
33. Lazarus HM, Gray R, Ciobanu N et al. A phase I trial of highdose melphalan, high-dose etoposide, and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study. Bone Marrow Transplant 1994; 14: 443-448.